ADMA Biologics
ADMA
ADMA
353 hedge funds and large institutions have $4.01B invested in ADMA Biologics in 2025 Q4 according to their latest regulatory filings, with 59 funds opening new positions, 139 increasing their positions, 118 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.66% more ownership
Funds ownership: 91.85% → 92.5% (+0.66%)
3% less first-time investments, than exits
New positions opened: 59 | Existing positions closed: 61
2% less funds holding
Funds holding: 362 → 353 (-9)
Holders
353
Holding in Top 10
8
Calls
$68.1M
Puts
$37M
Top Buyers
| 1 | +$64.7M | |
| 2 | +$57M | |
| 3 | +$43.5M | |
| 4 |
SHCM
Sachem Head Capital Management
New York
|
+$40.7M |
| 5 |
Fundsmith LLP
London,
United Kingdom
|
+$35.4M |
Top Sellers
| 1 | -$39.8M | |
| 2 | -$31.1M | |
| 3 | -$31M | |
| 4 |
Renaissance Technologies
New York
|
-$20.9M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$20.8M |
